Relation of a common variant of the adiponectin gene to serum adiponectin concentration and metabolic traits in an aged Japanese population

European Journal of Human Genetics

Volumn 19, Issue 3, 2011, Pages 262-269

  Tanimura, Daisuke ^a   Shibata, Rei ^a   Izawa, Hideo ^b   Hirashiki, Akihiro ^a   Asano, Hiroyuki ^a   Murase, Yosuke ^a   Miyata, Seiko ^c   Nakatochi, Masahiro ^c   Ouchi, Noriyuki ^d   Ichihara, Sahoko ^e   Yasui, Kenji ^f   Yoshida, Tsutomu ^g   Naruse, Keiko ^h   Matsubara, Tatsuaki ^h   Yokota, Mitsuhiro ^h  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MIE UNIVERSITY   (Japan)

^f Higashiyama Clinic   (Japan)

^g MEIJO UNIVERSITY   (Japan)

^h AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

adiponectin; epidemiology; hypertension; metabolic disorder; polymorphism

Indexed keywords

ADIPONECTIN; PRIMER DNA;

ADULT; AGING; ARTICLE; COLORIMETRY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC TRAIT; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADIPONECTIN; AGE FACTORS; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY MASS INDEX; DOWN-REGULATION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOM ALLOCATION;

EID: 79951810042     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.201     Document Type: Article

References (41)

1. Alberti KGMM, Zimmet P, Shaw J: Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
2. Lakka H-M, Laaksonen DE, Lakka TA et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716. (Pubitemid 35403784)
3. Yoshiike N, Seino F, Tajima S et al: Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976-95. Obes Rev 2002; 3: 183-190. (Pubitemid 34815237)
4. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29-33. (Pubitemid 38082408)
5. Vettor R, Milan G, Rossato M, Federspil G: Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther 2005; 22: 3-10. (Pubitemid 41564373)
6. Weyer C, Funahashi T, Tanaka S et al: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. (Pubitemid 32472900)
7. Hotta K, Funahashi T, Arita Y et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599. (Pubitemid 30353893)
8. Lindsay RS, Funahashi T, Hanson RL et al: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58. (Pubitemid 34756495)
9. Spranger J, Kroke A, Möhlig M et al: Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-228. (Pubitemid 36126226)
10. Li S, Shin HJ, Ding EL, Van Dam RM: Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302: 179-188.
11. Ryo M, Nakamura T, Kihara S et al: Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975-981. (Pubitemid 39540124)
12. Iwashima Y, Katsuya T, Ishikawa K et al: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318-1323. (Pubitemid 38691756)
13. Ouchi N, Kihara S, Arita Y et al: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476. (Pubitemid 30005109)
14. Kumada M, Kihara S, Sumitsuji S et al: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89. (Pubitemid 36091630)
15. Otsuka F, Sugiyama S, Kojima S et al: Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. Circ J 2007; 71: 1703-1709. (Pubitemid 350240089)
16. Snijder MB, Heine RJ, Seidell JC et al: Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn Study. Diabetes Care 2006; 29: 2498-2503. (Pubitemid 44912259)
17. Ouchi N, Ohishi M, Kihara S et al: Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003; 42: 231-234. (Pubitemid 37093465)
18. Francischetti EA, Celoria BMJ, Duarte SFP et al: Hypoadiponectinemia is associated with blood pressure increase in obese insulin-resistant individuals. Metabolism 2007; 56: 1464-1469. (Pubitemid 47562495)
19. Huang K-C, Chen C-L, Chuang L-M, Ho S-R, Tai T-Y, Yang W-S: Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 2003; 88: 4130-4134. (Pubitemid 37153709)
20. Iwashima Y, Horio T, Suzuki Y et al: Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis 2006; 188: 384-390. (Pubitemid 44301128)
21. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-1737. (Pubitemid 38489895)
22. Hu E, Liang P, Spiegelman BM: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-10703. (Pubitemid 26145805)
23. Gable DR, Hurel SJ, Humphries SE: Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006; 188: 231-244. (Pubitemid 44301148)
24. Kondo H, Shimomura I, Matsukawa Y et al: Association of adiponectin mutation with type 2 diabetes : a candidate gene for the insulin resistance syndrome. Diabetes 2002; 51: 2325-2328. (Pubitemid 34729044)
25. Ohashi K, Ouchi N, Kihara S et al: Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 2004; 43: 1195-1200. (Pubitemid 38452596)
26. Vasseur F, Helbecque N, Dina C et al: Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607-2614. (Pubitemid 35174690)
27. Schwarz PEH, Towers GW, Fischer S et al: Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006; 29: 1645-1650. (Pubitemid 44127594)
28. Hara K, Boutin P, Mori Y et al: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536-540. (Pubitemid 34764814)
29. Filippi E, Sentinelli F, Trischitta V et al: Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 2003; 12: 199-205.
30. Asano H, Izawa H, Nagata K et al: Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 2009; 53: 234-246.
31. Yamada Y, Izawa H, Ichihara S et al: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916-1923. (Pubitemid 35429921)
32. Heid IM, Wagner SA, Gohlke H et al: Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1727 healthy Caucasians. Diabetes 2006; 55: 375-384. (Pubitemid 43343266)
33. Menzaghi C, Ercolino T, Di Paola R et al: A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51: 2306-2312. (Pubitemid 34729040)
34. Sutton BS, Weinert S, Langefeld CD et al: Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS family study. Hum Genet 2005; 117: 107-118. (Pubitemid 43136787)
35. Hivert M-F, Manning AK, McAteer JB et al: Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring study. Diabetes 2008; 57: 3353-3359.
36. Heid IM, Henneman P, Hicks A et al: Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010; 208: 412-420.
37. Gu HF, Abulaiti A, Ostenson C-G et al: Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 2004; 53: S31-S35. (Pubitemid 38168690)
38. Mackevics V, Heid IM, Wagner SA et al: The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Eur J Hum Genet 2006; 14: 349-356.
39. Chow W-S, Cheung BMY, Tso AWK et al: Hypoadiponectinemia as a predictor for the development of hypertension: a 5-Year prospective study. Hypertension 2007; 49: 1455-1461. (Pubitemid 46809394)
40. Furuhashi M, Ura N, Higashiura K et al: Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003; 42: 76-81. (Pubitemid 36842239)
41. Ohashi K, Kihara S, Ouchi N et al: Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006; 47: 1108-1116. (Pubitemid 44289168)